In conclusion, we demonstrate for the first time that CXCL17 is mainly produced by tumor-infiltrating neutrophils and that it can be used as an independent indicator of poor prognosis for both OS and RFS in HCC. This evidence concerns the gene CXCL17 and neoplasm.